Kobylinska, L.; Lozynskii, A.; Lesyk, R.; Stoika, R.; Vari, S.G.
Biodistribution and Anticancer Characteristics of Les-3833, A Novel 4-thiazolidinone-Based Lead Compound. Sci. Pharm. 2020, 88, 18.
https://doi.org/10.3390/scipharm88020018
AMA Style
Kobylinska L, Lozynskii A, Lesyk R, Stoika R, Vari SG.
Biodistribution and Anticancer Characteristics of Les-3833, A Novel 4-thiazolidinone-Based Lead Compound. Scientia Pharmaceutica. 2020; 88(2):18.
https://doi.org/10.3390/scipharm88020018
Chicago/Turabian Style
Kobylinska, Lesya, Andrii Lozynskii, Roman Lesyk, Rostyslav Stoika, and Sandor G. Vari.
2020. "Biodistribution and Anticancer Characteristics of Les-3833, A Novel 4-thiazolidinone-Based Lead Compound" Scientia Pharmaceutica 88, no. 2: 18.
https://doi.org/10.3390/scipharm88020018
APA Style
Kobylinska, L., Lozynskii, A., Lesyk, R., Stoika, R., & Vari, S. G.
(2020). Biodistribution and Anticancer Characteristics of Les-3833, A Novel 4-thiazolidinone-Based Lead Compound. Scientia Pharmaceutica, 88(2), 18.
https://doi.org/10.3390/scipharm88020018